79 related articles for article (PubMed ID: 9000574)
1. Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
Dahia PL; Toledo SP; Mulligan LM; Maher ER; Grossman AB; Eng C
Cancer Res; 1997 Jan; 57(2):310-3. PubMed ID: 9000574
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
[TBL] [Abstract][Full Text] [Related]
3. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
[TBL] [Abstract][Full Text] [Related]
5. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
[TBL] [Abstract][Full Text] [Related]
6. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the RET and GDNF gene in children with hypoganglionosis.
Inoue K; Shimotake T; Tomiyama H; Iwai N
Eur J Pediatr Surg; 2001 Apr; 11(2):120-3. PubMed ID: 11371032
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
[TBL] [Abstract][Full Text] [Related]
9. A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.
Vanhorne JB; Andrew SD; Harrison KJ; Taylor SA; Thomas B; McDonald TJ; Ainsworth PJ; Mulligan LM
Oncogene; 2005 Feb; 24(6):1091-7. PubMed ID: 15592530
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
[TBL] [Abstract][Full Text] [Related]
11. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
12. The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation.
Gattei V; Degan M; Rossi FM; De Iuliis A; Mazzocco FT; Cesa E; Aldinucci D; Zagonel V; Pinto A
Br J Haematol; 1999 Apr; 105(1):225-40. PubMed ID: 10233387
[TBL] [Abstract][Full Text] [Related]
13. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes.
Bar M; Friedman E; Jakobovitz O; Leibowitz G; Lerer I; Abeliovich D; Gross DJ
Clin Endocrinol (Oxf); 1997 Dec; 47(6):707-12. PubMed ID: 9497878
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas.
van der Harst E; de Krijger RR; Bruining HA; Lamberts SW; Bonjer HJ; Dinjes WN; Proye C; Koper JW; Bosman FT; Roth J; Heitz PU; Komminoth P
Int J Cancer; 1998 Oct; 79(5):537-40. PubMed ID: 9761126
[TBL] [Abstract][Full Text] [Related]
15. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.
Hofstra RM; Stelwagen T; Stulp RP; de Jong D; Hulsbeek M; Kamsteeg EJ; van den Berg A; Landsvater RM; Vermey A; Molenaar WM; Lips CJ; Buys CH
J Clin Endocrinol Metab; 1996 Aug; 81(8):2881-4. PubMed ID: 8768845
[TBL] [Abstract][Full Text] [Related]
16. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
[TBL] [Abstract][Full Text] [Related]
17. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma.
Mulligan LM; Timmer T; Ivanchuk SM; Campling BG; Young LC; Rabbitts PH; Sundaresan V; Hofstra RM; Eng C
Genes Chromosomes Cancer; 1998 Apr; 21(4):326-32. PubMed ID: 9559344
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.
Edström E; Frisk T; Farnebo F; Höög A; Bäckdahl M; Larsson C
Int J Mol Med; 2000 Oct; 6(4):469-74. PubMed ID: 10998441
[TBL] [Abstract][Full Text] [Related]
20. Differences in allelic distribution of two polymorphisms in the VHL-associated gene CUL2 in pheochromocytoma patients without somatic CUL2 mutations.
Duerr EM; Gimm O; Neuberg DS; Kum JB; Clifford SC; Toledo SP; Maher ER; Dahia PL; Eng C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3207-11. PubMed ID: 10487688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
